Rapid clearance of achiral small-molecule drugs using de novo-designed proteins and their cyclic and mirror-image variants
- 29 May 2025
- journal article
- research article
- Published by Springer Nature in Nature Biomedical Engineering
- p. 1-13
Abstract
Small-molecule-binding proteins can neutralize toxins and cytotoxic drugs, but their development is hindered by unpredictable in vivo behaviour and the poor immunogenicity of small molecules, which limits antibody-based approaches. Here we present a strategy to engineer de novo-designed proteins for the effective clearance of Food and Drug Administration-approved drugs in healthy mice. As a proof of concept, we designed proteins that bind to the anticoagulant apixaban. Since apixaban lacks chirality, we used mirror-image synthesis and cyclization to enhance the designed protein’s in vivo stability. Both protein variants demonstrated effective activity, facilitating the rapid clearance of apixaban within 30 min. To assess the broader applicability of this approach, we extended our analysis to a de novo-designed protein targeting the anticancer drug rucaparib, further confirming its potential for small-molecule clearance. Our study shows that de novo-designed small-molecule-binding proteins can be used as antidotes in vivo, and that computational tools can be integrated with medicinal chemistry strategies for precise pharmacological interventions.Keywords
Funding Information
- National Natural Science Foundation of China (22077104)
- Science and Technology Department of Zhejiang Province (2021C03040)
This publication has 55 references indexed in Scilit:
- Racemic Protein CrystallographyAnnual Review of Biophysics, 2012
- Analysis of protein-ligand interactions by fluorescence polarizationNature Protocols, 2011
- Synthetic therapeutic peptides: science and marketDrug Discovery Today, 2010
- Albumin-bound paclitaxel: a next-generation taxaneExpert Opinion on Pharmacotherapy, 2006
- In Vivo Protein Cyclization Promoted by a Circularly Permuted Synechocystis sp. PCC6803 DnaB Mini-inteinJournal of Biological Chemistry, 2002
- Circular β‐lactamase: stability enhancement by cyclizing the backboneFEBS Letters, 1999
- Antibodies against small molecules.1991
- Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodiesJournal of Immunological Methods, 1989
- A correlation between protein thermostability and resistance to proteolysisBiochemical Journal, 1982
- The Isolation of Digoxin-Specific Antibody and Its Use in Reversing the Effects of DigoxinProceedings of the National Academy of Sciences, 1971